A third-party quality system assessment program proposed in a draft House “Cures” bill might be helpful to industry but would likely not be efficient for FDA, CDRH Director Jeff Shuren told lawmakers at an April 30 hearing on the draft bill.
The provision, crafted by Rep. John Shimkus, R-Ill., is given only placeholder text in the most recent draft, released April...